Cervical cancer is a type of cancer that originates in the cervix—the lower part of the uterus that connects to the vagina.

Supporting health authorities’ efforts to achieve national health indicators related to cervical cancer prevention and ...

Rural populations face unique challenges in cancer prevention and care. Geographic isolation, economic constraints, and a ...

The company has also partnered with the Tata Institute for Genetics and Society (TIGS) to develop an Indigenous HPV PCR kit, ...

In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...

Women in Papua New Guinea are being strongly encouraged to undergo early screening for cervical cancer to prevent the ...

In Côte d'Ivoire, nearly 90% of cervical cancer screenings are conducted through self-testing, empowering women to take charge of their health. This approach allows for detection in a private, ...

April marks the beginning of Oral & Head and Neck Cancer Awareness Month. This year, more than 50,000 new cases are expected ...

M-Strip, the self-sampling kit for cervical cancer (HPV) and STI screening, provides a non-invasive alternative to ...

IN a powerful response to the World Health Organisation’s call for the global elimination of cervical cancer by 2030, ...

The US giants which supply vital new medicines to UK patients face disruption from Donald Trump’s trade barriers, experts ...

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...